June 7, 2021 10:16 AM EDT
Financing

Der­ma­vant en­gi­neers $160M deal to pay off Glax­o­SmithK­line mile­stones, gear up to launch pso­ri­a­sis cream

Amber Tong

Der­ma­vant has nev­er been shy about its dreams to trans­form der­ma­tol­ogy with their top­i­cal cream. And the Roivant sub­sidiary has now found in­vestors just as …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Idor­sia eyes lay­offs, tees up Tryvio li­cens­ing deal to ex­tend cash run­way

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

Aca­dia snaps up an es­sen­tial tremor drug af­ter field­'s sum­mer set­backs

Re­cur­sion re­duces work­force; Ox­ford Nanopore teams up with UK Biobank

A service from the Financial Times